LadRx

LadRx Financial Leverage

The Financial Leverage (Equity Multiplier) of LadRx (LADX) as of Nov 4, 2026 is -0.59. In the previous year, Financial Leverage (Equity Multiplier) was 21.50 — a change of -102.75% (lower).

Financial Leverage

-0.59

YoY

-102.75%

Last updated:

Financial Leverage (Equity Multiplier) of LadRx is 2024 -0.59 . Financial Leverage (Equity Multiplier) of LadRx was 2023 21.50 . It decreases by -102.75% lower compared to the previous year.

The LadRx Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2018
1.13 USD
Jan 1, 2019
1.13 USD
Jan 1, 2020
1.36 USD
Jan 1, 2021
1.83 USD
Jan 1, 2022
87.36 USD
Jan 1, 2023
21.50 USD
Jan 1, 2024
-0.59 USD
The LadRx Financial Leverage history
YEARFinancial LeverageYoY
-0.59-102.75%
21.50-75.39%
87.36+4,681.20%
1.83+34.39%
1.36+19.80%
1.13+0.79%
1.13—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

LadRx Stock analysis

What does LadRx do? CytRx Corp. focuses on developing aldoxorubicin, a modified doxorubicin for cancer treatment, currently in Phase III trials for soft tissue sarcoma and multiple other cancer indications. The company generates revenue through clinical trial partnerships and potential future drug sales, targeting pharmaceutical companies and healthcare providers who require novel oncology treatments. CytRx's primary product, aldoxorubicin, is being evaluated in various cancer types including small cell lung cancer and glioblastoma, with additional pre-clinical development for DK049, an anti-cancer drug conjugate using LADR technology. The firm's revenue streams are derived from its clinical development programs and potential licensing agreements with partners in the oncology sector. LadRx is one of the most popular companies on Eulerpool.

Frequently Asked Questions about LadRx stock

Financial Leverage (Equity Multiplier) of LadRx is -0.59 in 2024.

Financial Leverage (Equity Multiplier) of LadRx changed from 21.50 to -0.59, representing a -102.75% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) LadRx since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s LadRx with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — LadRx

All Key Metrics — LadRx